Skip to content
Science and Education

    • The EMBL Genomics Core Facility

    The Illumina Genomics Podcast

    The EMBL Genomics Core Facility

    Jun 06, 2017 | Episode 3 | 14 mins

    Next generation sequencing, or NGS, has helped to fuel amazing scientific discoveries across a wide range of scientific disciplines. Dr. Vladimir Benes directs the EMBL Genomics Core Facility, and he recently sat down with us to discuss how genomics has impacted and enabled scientific research at EMBL and abroad.

    Audio Player
    00:00
    00:00
    00:00
    Download or subscribe to our recurring podcasts.
    Apple Podcasts Google Podcasts Spotify RSS

    Featured image by: Albrecht62, Creative Commons Attribution-ShareAlike 4.0 International

    For Research Use Only

    Not for use in diagnostic procedures (except as specifically noted).

    Innovative technologies

    At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.

    All trademarks are the property of Illumina, Inc. or their respective owners.
    For specific trademark information, see sapac.illumina.com/company/legal.html.

    © 2025 Illumina, Inc. All rights reserved.